Clearwater Analytics' $1.5 billion acquisition of Enfusion is a strategic move to expand its portfolio management offerings and enhance its SaaS revenue growth. Enfusion's strong business model ...

Investing.com -- Morgan Stanley downgraded Enfusion Inc (NYSE:ENFN) stock to "Equal-weight" from "Overweight" following Clearwater Analytics' proposed $1.5 billion acquisition at $11.25 per share.

(RTTNews) - Clearwater Analytics (CWAN) and Enfusion (ENFN) announced a definitive merger agreement for Clearwater to acquire Enfusion. Enfusion shareholders will receive consideration equal to $ ...

Clearwater Analytics Holdings Inc. today announced plans to acquire Enfusion Inc., a fellow provider of financial software, for $1.5 billion in cash and stock. The offer amounts to $11.5o per share.

Clearwater, which says it has obtained an $800 million loan to fund the transaction, along with a $200 million revolving line of credit, will let Enfusion’s shareholders elect to receive cash ...

By Arasu Kannagi Basil and Niket Nishant (Reuters) -Clearwater Analytics has agreed to acquire Enfusion in a $1.5 billion cash-and-stock deal as the financial software maker looks to bolster its ...

Jan 13 (Reuters) - Clearwater Analytics (CWAN.N), opens new tab has agreed to acquire Enfusion (ENFN.N), opens new tab in a $1.5 billion cash-and-stock deal as the financial software maker looks ...

The two firms have inked a definitive merger agreement for Clearwater to acquire Enfusion for $11.25 per share, delivered in an approximately equal mix of cash and stock. Clearwater will also pay ...